- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01845220
Prevention of Alcohol Intolerance
August 31, 2017 updated by: Johns Hopkins University
This study is designed to determine whether Asians who are especially sensitive to alcohol exposure can be protected by boosting their activities of an alcohol disposing enzyme.
This will be accomplished by administering broccoli sprouts that are rich in an agent that increases protective enzyme activity.
The test system involves applying alcohol patches to the skin and measuring skin redness.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21205
- Johns Hopkins University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18-70 years old,
- sensitive to alcohol on the skin, Japanese
Exclusion Criteria:
- recent skin abnormalities /tanning
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Broccoli Sprout Extract
Each subject will act as his/her own control and receive both treatment and placebo on adjacent skin regions.
|
150 nanomol of sulforaphane/cm2 of skin in 80% acetone for 3 applications on 3 successive days prior to alcohol challenge
|
Placebo Comparator: Placebo
Each subject will act as his/her own control and receive both treatment and placebo on adjacent skin regions.
|
80% acetone
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Area of Skin Erythema (Skin Redness)
Time Frame: mean up to 2 hours
|
For three days in a row, volunteers will receive skin treatments with broccoli sprout extract.
On day four, their skin will be measured for a baseline skin color reading.
Immediately following this reading, the treated areas of the skin will be challenged with 70 percent alcohol and the redness of the skin will again be measured every 30 minutes for the following two hours for skin color changes.
The values were collected every 30 minutes after the alcohol skin challenge for 2 hours and were averaged.
Mean and 95% Confidence Interval are reported.
|
mean up to 2 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2014
Primary Completion (Actual)
July 1, 2015
Study Completion (Actual)
July 1, 2015
Study Registration Dates
First Submitted
April 23, 2013
First Submitted That Met QC Criteria
May 1, 2013
First Posted (Estimate)
May 3, 2013
Study Record Updates
Last Update Posted (Actual)
September 29, 2017
Last Update Submitted That Met QC Criteria
August 31, 2017
Last Verified
August 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NA_00081276
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Sensitivity
-
University of VirginiaNational Institute on Alcohol Abuse and Alcoholism (NIAAA)TerminatedAlcohol Sensitivity | Alcohol-induced Cue-cravingUnited States
-
Assistance Publique Hopitaux De MarseilleCompletedThe Sweat Alcohol Concentration
-
University of PalermoCompletedNon-celiac Wheat Sensitivity | Non-celiac Gluten SensitivityItaly
-
Universidade Federal do ParaCompletedColor | Bleaching SensitivityBrazil
-
Vibrant America Clinical LabCompletedFood SensitivityUnited States
-
Balgrist University HospitalCompletedFood SensitivitySwitzerland
-
University of UtahUniversity of Colorado, DenverCompleted
-
University of New EnglandUniversity of IowaCompletedTooth Discoloration | Teeth SensitivityUnited States
-
Universidad Peruana Cayetano HerediaUniversity of WashingtonUnknownDental Sensitivity | Gingival ConditionPeru
-
Cairo UniversityUnknown
Clinical Trials on Broccoli Sprout Extract
-
Johns Hopkins UniversityCompleted
-
University of ArizonaNational Cancer Institute (NCI)CompletedCarcinoma in Situ | Head and Neck Cancer | Hyperplasia | Head and Neck Squamous Cell Carcinoma | HNSCC | Dysplasia | Tobacco-Related Carcinoma | Premalignant LesionUnited States
-
National Cancer Institute (NCI)CompletedCigarette Smoking-Related Carcinoma | Tobacco-Related CarcinomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)Completed
-
Johns Hopkins UniversityCompletedEpidermolysis Bullosa Simplex | Pachyonychia CongenitaUnited States
-
Fred Hutchinson Cancer CenterJohns Hopkins University; University of Washington; Cedars-Sinai Medical Center; VA Puget Sound Health Care System and other collaboratorsCompleted
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)CompletedBreast Cancer | Precancerous ConditionUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedInvasive Breast Carcinoma | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | Lobular Breast Carcinoma | Postmenopausal | Ductal Breast Carcinoma | Ductal Breast Carcinoma In SituUnited States
-
National Cancer Institute (NCI)RecruitingCigarette Smoking-Related CarcinomaUnited States
-
Johns Hopkins Bloomberg School of Public HealthJohns Hopkins University; University of Pittsburgh; University of Minnesota; National... and other collaboratorsCompleted